Clinical Trial Update: Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW) [Phase 3]

View source ↗

Summary

The SAFE-LOW Phase 3 trial evaluating low-dose glucocorticoids for ANCA-associated vasculitis is currently recruiting, focusing on granulomatosis with polyangii…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Granulomatosis With Polyangiitis, Microscopic Polyangiitis (MPA) | Phase 3 | Status: RECRUITING